Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Cash from Investing Activities (2020 - 2026)

Immuneering's Cash from Investing Activities history spans 7 years, with the latest figure at -$63.1 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 704995.3% to -$63.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$151.8 million, a 3115.8% decrease, with the full-year FY2025 number at -$88.7 million, down 435.69% from a year prior.
  • Cash from Investing Activities came in at -$63.1 million for Q1 2026, up from -$88.7 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $22.2 million in Q2 2022, with the low at -$88.7 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$4.5 million across 5 years, with a median of $3.1 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 111852.97% in 2022 and later tumbled 704995.3% in 2026.
  • Year by year, Cash from Investing Activities stood at $8.2 million in 2022, then plummeted by 61.57% to $3.1 million in 2023, then skyrocketed by 75.26% to $5.5 million in 2024, then plummeted by 1715.84% to -$88.7 million in 2025, then increased by 28.91% to -$63.1 million in 2026.
  • Business Quant data shows Cash from Investing Activities for IMRX at -$63.1 million in Q1 2026, -$88.7 million in Q4 2025, and -$7255.0 in Q3 2025.